Sesen Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sesen Bio generated cash of $24,895,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,000 last year. Net change in cash is therefore -$29,073,000.
Cash Flow
| 2013 | -13.49M | 0 | 13.55M |
|---|---|---|---|
| 2014 | -29.30M | -137K | 75.56M |
| 2015 | -34.52M | -287K | 16.83M |
| 2016 | 2.62M | 461K | -13.82M |
| 2017 | -17.76M | 98K | 7.00M |
| 2018 | -22.82M | -2K | 58.58M |
| 2019 | -37.52M | -136K | 35.35M |
| 2020 | -30.83M | -8K | 38.11M |
| 2021 | -68.87M | -4K | 176.12M |
| 2022 | 24.89M | -53.96M | 1K |
SESN Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 162.65M | 55.40M | 48.14M | 50.44M | 14.69M | 25.34M | 36.07M | 54.05M | 7.94M | 7.88M |
Operating activities | ||||||||||
Net income | -19.88M | -336K | -22.39M | -107.5M | -33.69M | -29.02M | 1.89M | -33.45M | -34.15M | -18.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 13K | 85K | 122K | 219K | 208K | 285K | 178K | 366K | 410K | 438K |
Stock-based compensation expense | 6.90M | 5.14M | 1.75M | 1.23M | 1.28M | 1.38M | 4.01M | 2.52M | 2.43M | 1.26M |
| Deferred income tax benefit | 6.90M | 5.14M | 1.75M | 1.23M | 1.28M | 1.38M | 4.01M | 2.52M | 2.43M | 1.26M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 21.01M | -24.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | -22.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.62M | -249K | 1.2M | 535K | 460K | -760K | -742K | -1.21M | 1.02M | -211K |
Cash generated by operating activities | 24.89M | -68.87M | -30.83M | -37.52M | -22.82M | -17.76M | 2.62M | -34.52M | -29.30M | -13.49M |
Investing activities | ||||||||||
Purchases Of Investments | -128.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -4K | -8K | -136K | -2K | 98K | 325K | -287K | -137K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 136K | 0 | 0 | 0 |
Cash generated by investing activities | -53.96M | -4K | -8K | -136K | -2K | 98K | 461K | -287K | -137K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 1K | 174.96M | 37.95M | 29.76M | 58.28M | 6.90M | 35K | 12.65M | 70.23M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 2.67M | 0 | 328K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | -14.12M | 0 | -4.63M | -511K |
Cash used in financing activities | 1K | 176.12M | 38.11M | 35.35M | 58.58M | 7.00M | -13.82M | 16.83M | 75.56M | 13.55M |
Net Change In Cash | -29.07M | 107.24M | 7.26M | -2.30M | 35.75M | -10.66M | -10.73M | -17.98M | 46.11M | 60K |
Cash at end of period | 133.58M | 162.65M | 55.40M | 48.14M | 50.44M | 14.68M | 25.34M | 36.07M | 54.05M | 7.94M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |